These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 1654766

  • 21. Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors.
    Bylund DB.
    J Pharmacol Exp Ther; 1981 Apr; 217(1):81-6. PubMed ID: 6110776
    [Abstract] [Full Text] [Related]

  • 22. Topographic distribution of choline acetyltransferase activity and muscarinic and nicotinic receptors in Parkinson brains.
    Nordberg A, Nyberg P, Windblad B.
    Neurochem Pathol; 1985 Apr; 3(4):223-36. PubMed ID: 3831845
    [Abstract] [Full Text] [Related]

  • 23. Muscarinic cholinergic receptor sites in cerebral blood vessels.
    Estrada C, Krause DN.
    J Pharmacol Exp Ther; 1982 Apr; 221(1):85-90. PubMed ID: 7062294
    [Abstract] [Full Text] [Related]

  • 24. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J, Brown JH.
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [Abstract] [Full Text] [Related]

  • 25. Reduced muscarinic receptor binding in tissues of rats tolerant to the insecticide disulfoton.
    Schwab BW, Hand H, Costa LG, Murphy SD.
    Neurotoxicology; 1981 Dec; 2(4):635-47. PubMed ID: 7200580
    [Abstract] [Full Text] [Related]

  • 26. Neurotransmitter receptor alterations in Parkinson's disease.
    Reisine TD, Fields JZ, Yamamura HI.
    Life Sci; 1977 Aug 01; 21(3):335-43. PubMed ID: 197361
    [No Abstract] [Full Text] [Related]

  • 27. Pituitary cell cultures contain muscarinic receptors.
    Taylor RL, Burt DR.
    Eur J Pharmacol; 1980 Jul 25; 65(2-3):305-8. PubMed ID: 6249627
    [Abstract] [Full Text] [Related]

  • 28. Dopamine receptors in the Parkinsonian brain.
    Rinne UK, Lönnberg P, Koskinen V.
    J Neural Transm; 1981 Jul 25; 51(1-2):97-106. PubMed ID: 6114985
    [Abstract] [Full Text] [Related]

  • 29. Muscarinic and dopaminergic receptors in the aging human brain.
    Rinne JO.
    Brain Res; 1987 Feb 24; 404(1-2):162-8. PubMed ID: 3567563
    [Abstract] [Full Text] [Related]

  • 30. L-dopa reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum.
    Guttman M, Seeman P.
    J Neural Transm; 1985 Feb 24; 64(2):93-103. PubMed ID: 2934514
    [Abstract] [Full Text] [Related]

  • 31. Alterations in [3H]spiperone binding in human caudate nucleus, substantia nigra and frontal cortex in the Shy-Drager syndrome and Parkinson's disease.
    Quik M, Spokes EG, Mackay AV, Bannister R.
    J Neurol Sci; 1979 Nov 24; 43(3):429-37. PubMed ID: 521836
    [Abstract] [Full Text] [Related]

  • 32. Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats.
    Suga M.
    Life Sci; 1980 Sep 08; 27(10):877-82. PubMed ID: 7412476
    [No Abstract] [Full Text] [Related]

  • 33. A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease.
    Griffiths PD, Perry RH, Crossman AR.
    Neurosci Lett; 1994 Mar 14; 169(1-2):68-72. PubMed ID: 8047295
    [Abstract] [Full Text] [Related]

  • 34. Distribution of cholinergic and dopaminergic receptors in rainbow trout pineal gland.
    Samejima M, Happe HK, Murrin LC, Pfeiffer RF, Ebadi M.
    J Pineal Res; 1994 Jan 14; 16(1):37-43. PubMed ID: 8158522
    [Abstract] [Full Text] [Related]

  • 35. Loss of D1 and D2 dopamine receptors and muscarinic cholinergic receptors in rat brain following in vitro polytron homogenization.
    Norman AB, Borchers MT, Wachendorf TJ, Price AL, Sanberg PR.
    Brain Res Bull; 1989 Apr 14; 22(4):633-6. PubMed ID: 2660951
    [Abstract] [Full Text] [Related]

  • 36. Changes in benzodiazepine and acetylcholine receptors in the globus pallidus in Parkinson's disease.
    Griffiths PD, Sambrook MA, Perry R, Crossman AR.
    J Neurol Sci; 1990 Dec 14; 100(1-2):131-6. PubMed ID: 1965202
    [Abstract] [Full Text] [Related]

  • 37. Cholinergic and dopaminergic alterations in the mouse central nervous system following acute trimethyltin exposure.
    Ali SF, Slikker W, Newport GD, Goad PT.
    Acta Pharmacol Toxicol (Copenh); 1986 Sep 14; 59(3):179-88. PubMed ID: 2879410
    [Abstract] [Full Text] [Related]

  • 38. Changes in brain striatum dopamine and acetylcholine receptors induced by chronic CDP-choline treatment of aging mice.
    Giménez R, Raïch J, Aguilar J.
    Br J Pharmacol; 1991 Nov 14; 104(3):575-8. PubMed ID: 1839138
    [Abstract] [Full Text] [Related]

  • 39. Murine lymphocytes lack clearly defined receptors for muscarinic and dopaminergic ligands.
    Wazer DE, Rotrosen J.
    J Pharm Pharmacol; 1984 Dec 14; 36(12):853-4. PubMed ID: 6151985
    [Abstract] [Full Text] [Related]

  • 40. Regional and cortical laminar distributions of serotonin S2, benzodiazepine, muscarinic, and dopamine D2 receptors in human brain.
    Luabeya MK, Maloteaux JM, Laduron PM.
    J Neurochem; 1984 Oct 14; 43(4):1068-71. PubMed ID: 6088690
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.